250
Participants
Start Date
October 15, 2017
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Pacemaker implant
Patient will be in the electrophysiology laboratory. The doctor will freeze the groin area and a medication may be given to help the patient relax. A catheter will be inserted into the groin up to the heart and the heart's electrical system will be recorded.
Transcutaneous cardiac monitor
"Transcutaneous cardiac patches will allow continuous electrocardiographic monitoring for a 30-day period. For the first randomized patients at the Montreal Heart Institute, Icentia was used and then was changed to a m-Health® device which allows continuous cardiac monitoring. The PocketECG from m-Health® is attached to 3 electrodes on the chest and contains a SIM card that transmits to a server located in Burlington, Ontario .The COME-TAVI coordinating center and the associated site will be informed rapidly of any events that occur . These events include:~Ventricular fibrillation; Sustained ventricular tachycardia Any RR interval \>5 sec; Third-degree AV block or Mobitz 2 AV block;"
RECRUITING
Mazankowski Alberta Heart Institute, Edmonton
NOT_YET_RECRUITING
New Brunswick Heart Center, Saint John
RECRUITING
QEII Health Sciences Center, Halifax
RECRUITING
Hamilton Health Sciences Corporation, Hamilton
RECRUITING
London Health Sciences Center (LHSC), London
RECRUITING
University of Ottawa Heart Institute (UOHI), Ottawa
RECRUITING
CIUSSS du Nord de l'Île de Mtl, Montreal
NOT_YET_RECRUITING
Centre Hospitalier Universitaire de Nantes, Nantes
RECRUITING
Montreal Heart Institute, Montreal
RECRUITING
Centre hospitalier universitaire de Sherbrooke, Sherbrooke
Montreal Heart Institute
OTHER